Switch from tenofovir DF to raltegravir is not associated with weight gain over 96 weeks.
Sign Up to like & getrecommendations! Published in 2019 at "AIDS"
DOI: 10.1097/qad.0000000000002473
Abstract: : Integrase inhibitor-based antiretroviral therapy (INSTI-ART) can cause weight gain. It is unknown if this is a class effect, with limited data regarding raltegravir. In 37 virologically suppressed adults (36 men, mean age 49 years)… read more here.
Keywords: raltegravir associated; tenofovir raltegravir; raltegravir; weight gain ... See more keywords